CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts-Reference-Cited by-同舟云学术

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

Published:2010-02-01 Issue:2 Volume:120 Page:485-497
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Ginestier Christophe,Liu Suling,Diebel Mark E.,Korkaya Hasan,Luo Ming,Brown Marty,Wicinski Julien,Cabaud Olivier,Charafe-Jauffret Emmanuelle,Birnbaum Daniel,Guan Jun-Lin,Dontu Gabriela,Wicha Max S.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference39 articles.

1. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

2. Stem cells, cancer, and cancer stem cells

3. Efficient tumour formation by single human melanoma cells

4. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells

5. The Response of CD24 −/low /CD44 + Breast Cancer–Initiating Cells to Radiation

Cited by 635 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

2. The CXCR2 chemokine receptor: A new target for gastric cancer therapy;Cytokine;2024-09

3. Inhibition of STAT3/Fanconi anemia axis by Nifuroxazide is synthetic lethal with PARP inhibitor and selectively targets breast cancer stem cells;2024-08-28

4. Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies;Journal of Cellular Physiology;2024-05-28

5. 3D Bioprinted Tumor-Stroma Models of Triple-Negative Breast Cancer Stem Cells for Preclinical Targeted Therapy Evaluation;ACS Applied Materials & Interfaces;2024-05-20